Cannabinoid Medication for Adults With OCD

NCT02911324 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Obsessive-Compulsive Disorder

Interventions

DRUG: Nabilone
BEHAVIORAL: Exposure and Response Prevention Therapy

Sponsor

New York State Psychiatric Institute